Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kardigan Inc | 0 | 15,042,036 | +15,042,036 | $0 | $221.87M | 13.75% | +$221.87M |
| Parabilis Medicines Inc | 6,412,780 | 6,412,780 | 0 | $175.52M | $207.07M | 12.83% | +$31.55M |
| Vir Biotechnology, Inc.(VIR) | 12,694,163 | 12,694,163 | 0 | $129.35M | $141.92M | 8.80% | +$12.57M |
| Sana Biotechnology Inc | 0 | 45,860,681 | +45,860,681 | $0 | $133.68M | 8.29% | +$133.68M |
| Seaport Therapeutics Inc | 6,294,951 | 6,294,951 | 0 | $136.60M | $126.97M | 7.87% | -$9.63M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $155.38M | $125.29M | 7.77% | -$30.09M |
| Scholar Rock Holding Corporation(SRRK) | 0 | 2,345,711 | +2,345,711 | $0 | $113.34M | 7.03% | +$113.34M |
| Maze Therapeutics, Inc.(MAZE) | 4,120,053 | 4,120,053 | 0 | $122.98M | $111.98M | 6.94% | -$11.00M |
| Beam Therapeutics Inc.(BEAM) | 4,540,132 | 4,540,132 | 0 | $155.77M | $111.01M | 6.88% | -$44.77M |
| Erasca, Inc.(ERAS) | 7,091,557 | 7,091,557 | 0 | $129.92M | $103.96M | 6.44% | -$25.96M |
| 908 Devices Inc | 0 | 5,725,045 | +5,725,045 | $0 | $70.65M | 4.38% | +$70.65M |
| Prime Medicine, Inc.(PRME) | 0 | 18,486,894 | +18,486,894 | $0 | $56.48M | 3.50% | +$56.48M |
| Lyell Immunopharma Inc | 3,247,162 | 3,247,162 | 0 | $45.53M | $31.79M | 1.97% | -$13.74M |
| Generate Biomedicines, Inc.(GENB) | 1,944,426 | 1,944,426 | 0 | $32.80M | $29.21M | 1.81% | -$3.60M |
| Neumora Therapeutics Inc. | 0 | 33,847,838 | +33,847,838 | $0 | $20.18M | 1.25% | +$20.18M |
| Boundless Bio Inc | 2,694,095 | 2,694,095 | 0 | $6.74M | $6.76M | 0.42% | +$26.9K |
| Gossamer Bio Inc | 0 | 100,698 | +100,698 | $0 | $1.19M | 0.07% | +$1.19M |
| 10x Genomics, Inc.CL A(TXG) | 217,834 | 0 | -217,834 | $8.35M | $0 | — | -$8.35M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 0 | -8,055,916 | $1.33M | $0 | — | -$1.33M |